Document is current
Any future updates will be listed below
-
Authors
Brenneman, Douglas E.
Petkanas, Dean
Ippolito, Michael
Ward, Sara Jane
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R42NS120548, R42NS120548, R42NS120548, R42NS120548)
- License Information
-
More Information
Article History
Received: 31 December 2024
Accepted: 20 February 2025
First Online: 14 March 2025
Declarations
:
: This research did not involve animal or human subjects.
: Dr. Brenneman is a patent holder of KLS-13019, an antagonist to the GPR55 receptor which is mentioned in this paper. Dr. Brenneman in on the editorial board of the Journal of Molecular Neuroscience.
